Fraud Breeds Retractions

An analysis of retractions dating back to 1977 shows that most papers are retracted due to misconduct.

| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

Scientific misconduct contributes to more retractions than previously realized, according to a new analysis published today (October 1) in Proceedings of the National Academy of Sciences. Using retractions indexed in Pubmed, researchers found that fabrication, falsification, and duplication led to more retractions than error or plagiarism.

“Tracking down these corrections and retractions to find out what is going on is really innovative,” said David Resnik, a bioethicist at the National Institute of Environmental Health Sciences, who did not participate in the research. It turns out that “a high percentage of time, there really some kind of misconduct” behind retractions.

Previous studies suggested that error, not ethical lapses, prompted most retractions. In order to get a clearer sense of what mistakes led to scientific studies being pulled from the literature, lead author Arturo Casadevall at Albert Einstein College of Medicine and his colleagues identified more than 2,000 articles listed in Pubmed ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to more than 35 years of archives, as well as TS Digest, digital editions of The Scientist, feature stories, and much more!
Already a member? Login Here

Keywords

Meet the Author

  • Sabrina Richards

    This person does not yet have a bio.
Share
TS Digest January 2025
January 2025, Issue 1

Why Do Some People Get Drunk Faster Than Others?

Genetics and tolerance shake up how alcohol affects each person, creating a unique cocktail of experiences.

View this Issue
Sex Differences in Neurological Research

Sex Differences in Neurological Research

bit.bio logo
New Frontiers in Vaccine Development

New Frontiers in Vaccine Development

Sino
New Approaches for Decoding Cancer at the Single-Cell Level

New Approaches for Decoding Cancer at the Single-Cell Level

Biotium logo
Learn How 3D Cell Cultures Advance Tissue Regeneration

Organoids as a Tool for Tissue Regeneration Research 

Acro 

Products

Artificial Inc. Logo

Artificial Inc. proof-of-concept data demonstrates platform capabilities with NVIDIA’s BioNeMo

Sapient Logo

Sapient Partners with Alamar Biosciences to Extend Targeted Proteomics Services Using NULISA™ Assays for Cytokines, Chemokines, and Inflammatory Mediators

Bio-Rad Logo

Bio-Rad Extends Range of Vericheck ddPCR Empty-Full Capsid Kits to Optimize AAV Vector Characterization

Scientist holding a blood sample tube labeled Mycoplasma test in front of many other tubes containing patient samples

Accelerating Mycoplasma Testing for Targeted Therapy Development